Delstrigo
FDA Grants New Indication for NNRTIs Delstrigo and Pifeltro
The FDA granted a new indication for Merck’s two doravirine-based HIV therapies that allows adults who are ...
SEPTEMBER 20, 2019
FDA Accepts sNDAs for Pifeltro and Delstrigo
The FDA agreed to review a supplemental New Drug Applications (sNDAs) for Merck’s Pifeltro and Delstrigo for ...
JANUARY 23, 2019
Delstrigo Demonstrates Long-Term HIV Suppression
Adults with HIV who were switched to the once-daily, fixed-dose Delstrigo combination tablet saw virologic ...
OCTOBER 5, 2018
FDA Approves Delstrigo and Pifeltro for HIV Treatment
The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...
AUGUST 30, 2018
Load more